Cornell University
New York, 10021, United States
NCT Number: NCT00011141
The etiology of immune-mediated diabetes mellitus (IMD) remains unclear. However, previous studies indicate that autoimmunity may be a result of dysfunction of natural killer T cells (NK-T cells). Newly diagnoses patients with IMD have been shown in our laboratory to have significantly lower NK-T cells than normal controls. Other studies have shown that oral administration of lactobacillus can boost NK-T cell activity in children with HIV without side effects. Our objective is to evaluate the effect of lactobacillus administration on NK-T cell activity in patients with IMD
Looking for future studies?
Notify Me1 year–95 year
All sexes
Interventional
Not applicable
New York, 10021, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Recently diagnosed (within the last 6 months) patients with immune-mediated (type 1) diabetes
National Center for Research Resources (NCRR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06186245
Acid-Base Imbalance, Acidosis
Lubbock, Texas, United States
View Trial DetailsNCT07800884
Diabetes Mellitus, Diet Interventions
Jakarta, DKI Jakarta, Indonesia
View Trial DetailsNCT07779044
Behavior, Behavioral Symptoms
Damascus, Damascus Governorate, Syria
View Trial DetailsNCT03076697
Age Related Macular Degeneration, Cardiovascular Diseases
View Trial Details